Home
>
National Drug Code (NDC)
>
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE - 0115-3511-02 - (PYRIDOSTIGMINE BROMIDE)
Drug Information of PYRIDOSTIGMINE BROMIDE
| Product NDC: | 0115-3511 |
| Proprietary Name: | PYRIDOSTIGMINE BROMIDE |
| Non Proprietary Name: | PYRIDOSTIGMINE BROMIDE |
| Active Ingredient(s): | 60 mg/1 & nbsp; PYRIDOSTIGMINE BROMIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PYRIDOSTIGMINE BROMIDE
| Product NDC: | 0115-3511 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040502 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030424 |
Package Information of PYRIDOSTIGMINE BROMIDE
| Package NDC: | 0115-3511-02 |
| Package Description: | 500 TABLET in 1 BOTTLE (0115-3511-02) |
NDC Information of PYRIDOSTIGMINE BROMIDE
| NDC Code | 0115-3511-02 |
| Proprietary Name | PYRIDOSTIGMINE BROMIDE |
| Package Description | 500 TABLET in 1 BOTTLE (0115-3511-02) |
| Product NDC | 0115-3511 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PYRIDOSTIGMINE BROMIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20030424 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
